Vistagen Therapeutics Inc

Vistagen’s coordinated incentive‑stock option grants signal executive confidence amid volatile biotech markets—unlocking value potential as regulatory milestones loom.

Vistagen’s insider option grants signal executive confidence in its CNS therapeutics, outlining how equity, cash‑sparing strategy, and digital‑health partnerships could drive post‑milestone growth and valuation.